Skip to main content
Top
Published in: Current Hypertension Reports 5/2012

01-10-2012 | Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Perioperative Hypertension: Defining At-Risk Patients and Their Management

Authors: Susan F. Lien, John D. Bisognano

Published in: Current Hypertension Reports | Issue 5/2012

Login to get access

Abstract

Hypertension is an extremely pervasive condition that affects a large percentage of the world population. Although guidelines exist for the treatment of the patient with elevated blood pressure, there remains a paucity of literature and accepted guidelines for the perioperative evaluation and care of the patient with hypertension who undergoes either cardiac or noncardiac surgery. Of particular importance is defining the patients most vulnerable to complications and the indications for immediate and rapid antihypertensive treatment and/or cancellation of surgery to reduce these risks in each of the three perioperative settings: preoperative, intraoperative, and postoperative. This review also examines the parenteral antihypertensive medications most commonly administered in the perioperative setting.
Literature
2.
go back to reference Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
3.
go back to reference Erstad BL, Barletta JF. Treatment of hypertension in the perioperative patient. Ann Pharmacother. 2000;34:66–79.PubMedCrossRef Erstad BL, Barletta JF. Treatment of hypertension in the perioperative patient. Ann Pharmacother. 2000;34:66–79.PubMedCrossRef
4.
go back to reference • Varon J and Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615–627. This reference is of importance as it nicely reviews management strategies of perioperative hypertension.PubMed • Varon J and Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615–627. This reference is of importance as it nicely reviews management strategies of perioperative hypertension.PubMed
5.
go back to reference Skarvan K. Perioperative hypertension: new strategies for management. Curr Opin Anaesthesiol. 1998;11(1):29–35.PubMedCrossRef Skarvan K. Perioperative hypertension: new strategies for management. Curr Opin Anaesthesiol. 1998;11(1):29–35.PubMedCrossRef
6.
go back to reference Hanada S, Kawakami H, Goto T, et al. Hypertension and anesthesia. Curr Opin Anaesthesiol. 2006;19:315–9.PubMedCrossRef Hanada S, Kawakami H, Goto T, et al. Hypertension and anesthesia. Curr Opin Anaesthesiol. 2006;19:315–9.PubMedCrossRef
7.
go back to reference Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease, and perioperative cardiac risk. Br J Anaesth. 2004;92:570–83.PubMedCrossRef Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease, and perioperative cardiac risk. Br J Anaesth. 2004;92:570–83.PubMedCrossRef
8.
go back to reference Feneck R. Drugs for the perioperative control of hypertension: current issues and future directions. Drugs. 2007;67(14):2023–44.PubMedCrossRef Feneck R. Drugs for the perioperative control of hypertension: current issues and future directions. Drugs. 2007;67(14):2023–44.PubMedCrossRef
9.
go back to reference • Marik PE and Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth. 2009;21:220–229. This reference is of importance as it focuses on commonly used parenteral antihypertensive agents used in the management of perioperative hypertension. PubMedCrossRef • Marik PE and Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth. 2009;21:220–229. This reference is of importance as it focuses on commonly used parenteral antihypertensive agents used in the management of perioperative hypertension. PubMedCrossRef
10.
go back to reference Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85:342–50.PubMedCrossRef Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85:342–50.PubMedCrossRef
11.
go back to reference Gravlee GP. Perioperative hypertension. Semin Anesth Perioperat Med Pain. 1998;17(2):87–92.CrossRef Gravlee GP. Perioperative hypertension. Semin Anesth Perioperat Med Pain. 1998;17(2):87–92.CrossRef
12.
go back to reference • Ahuja, K and Charap MH. Management of perioperative hypertensive urgencies with parenteral medications. J Hosp Med. 2010;5:E11–E16. This reference is of importance as it focuses on parenteral antihypertensive agents in the management of hypertensive urgency in the perioperative setting. PubMedCrossRef • Ahuja, K and Charap MH. Management of perioperative hypertensive urgencies with parenteral medications. J Hosp Med. 2010;5:E11–E16. This reference is of importance as it focuses on parenteral antihypertensive agents in the management of hypertensive urgency in the perioperative setting. PubMedCrossRef
13.
go back to reference Prys-Roberts C, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension: cardiovascular responses of treated and untreated patients. Br J Anaesth. 1971;43:122–37.PubMedCrossRef Prys-Roberts C, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension: cardiovascular responses of treated and untreated patients. Br J Anaesth. 1971;43:122–37.PubMedCrossRef
14.
go back to reference Prys-Roberts C, Greene LT, Meloche R, et al. Studies of anaesthesia in relation to hypertension: haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth. 1971;43:531–47.PubMedCrossRef Prys-Roberts C, Greene LT, Meloche R, et al. Studies of anaesthesia in relation to hypertension: haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth. 1971;43:531–47.PubMedCrossRef
15.
go back to reference Howell SJ, Sear YM, Yeates D, et al. Hypertension, admission blood pressure and perioperative cardiovascular risk. Anaesthesia. 1996;51:1000–4.PubMedCrossRef Howell SJ, Sear YM, Yeates D, et al. Hypertension, admission blood pressure and perioperative cardiovascular risk. Anaesthesia. 1996;51:1000–4.PubMedCrossRef
16.
go back to reference Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation. 2007;116:e418–500.PubMedCrossRef Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation. 2007;116:e418–500.PubMedCrossRef
17.
go back to reference Weksler N, Klein M, Szendro G, et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? J Clin Anesth. 2003;15:179–83.PubMedCrossRef Weksler N, Klein M, Szendro G, et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? J Clin Anesth. 2003;15:179–83.PubMedCrossRef
18.
go back to reference Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81:299–307.PubMedCrossRef Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81:299–307.PubMedCrossRef
19.
go back to reference Brabant SM, Bertrand M, Eyraud D, et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89:1388–92.PubMed Brabant SM, Bertrand M, Eyraud D, et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89:1388–92.PubMed
20.
go back to reference • Bisognano JD and Fong MW. Perioperative management of hypertension. In: Izzo JL, Black HR, Sica DA, editors. Hypertension primer: the essentials of high blood pressure. Dallas, Texas: Lippincott Williams & Wilkins; 2008 553–556. This reference is of importance as it describes the common causes of perioperative hypertension and the appropriate treatment for the preoperative, intraoperative, and postoperative settings. • Bisognano JD and Fong MW. Perioperative management of hypertension. In: Izzo JL, Black HR, Sica DA, editors. Hypertension primer: the essentials of high blood pressure. Dallas, Texas: Lippincott Williams & Wilkins; 2008 553–556. This reference is of importance as it describes the common causes of perioperative hypertension and the appropriate treatment for the preoperative, intraoperative, and postoperative settings.
21.
go back to reference Nunnelee JD, Spaner SD. Assessment and nursing management of hypertension in the perioperative period. J Perianesthes Nurs. 2000;15(3):163–8.CrossRef Nunnelee JD, Spaner SD. Assessment and nursing management of hypertension in the perioperative period. J Perianesthes Nurs. 2000;15(3):163–8.CrossRef
22.
go back to reference Cohn JN, Franciosa JA, Francis GS, et al. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med. 1982;306:1129–35.PubMedCrossRef Cohn JN, Franciosa JA, Francis GS, et al. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med. 1982;306:1129–35.PubMedCrossRef
23.
go back to reference Levy JH. Treatment of perioperative hypertension. Anesthesiol Clin. 1999;17(3):567–79.CrossRef Levy JH. Treatment of perioperative hypertension. Anesthesiol Clin. 1999;17(3):567–79.CrossRef
24.
go back to reference Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60.PubMedCrossRef Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60.PubMedCrossRef
25.
go back to reference Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of hypertension and hypertensive emergencies. Am J Cardiol. 1988;62:1062–7.CrossRef Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of hypertension and hypertensive emergencies. Am J Cardiol. 1988;62:1062–7.CrossRef
26.
go back to reference IV Nicardipine Study Group. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. Chest. 1991;99:393–8.CrossRef IV Nicardipine Study Group. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. Chest. 1991;99:393–8.CrossRef
27.
go back to reference • Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE Trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110–1121. This reference is important as it focuses on clevidipine and its effectivness in controlling perioperative hypertension. PubMedCrossRef • Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE Trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110–1121. This reference is important as it focuses on clevidipine and its effectivness in controlling perioperative hypertension. PubMedCrossRef
Metadata
Title
Perioperative Hypertension: Defining At-Risk Patients and Their Management
Authors
Susan F. Lien
John D. Bisognano
Publication date
01-10-2012
Publisher
Current Science Inc.
Published in
Current Hypertension Reports / Issue 5/2012
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-012-0287-2

Other articles of this Issue 5/2012

Current Hypertension Reports 5/2012 Go to the issue

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Blood Pressure Variability, Cardiovascular Risk, and Risk for Renal Disease Progression

Antihypertensive Therapy: Patient Selection and Special Problems (K Kario and H Rakugi, Section Editors)

Salt Sensitivity and Nondippers in Chronic Kidney Disease

Antihypertensive Therapy: Patient Selection and Special Problems (K Kario and H Rakugi, Section Editors)

Characteristics of Hypertension in the Chinese Population

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

The Kidney and Hypertension: Pathogenesis of Salt-Sensitive Hypertension

Antihypertensive Therapy: Patient Selection and Special Problems (K Kario and H Rakugi, Section Editors)

Disaster Hypertension: Experience from the Great East Japan Earthquake of 2011

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.